|
gptkbp:instanceOf
|
gptkb:drug
synthetic progestin
|
|
gptkbp:ATCCode
|
G03AC09
|
|
gptkbp:CASNumber
|
67392-87-4
|
|
gptkbp:component
|
gptkb:Angeliq
gptkb:Yaz
gptkb:Yasmin
oral contraceptive
|
|
gptkbp:contraindication
|
renal impairment
adrenal insufficiency
hepatic impairment
|
|
gptkbp:discoveredBy
|
gptkb:Schering_AG
|
|
gptkbp:eliminationHalfLife
|
30 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:hasMolecularFormula
|
C24H30O3
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
drospirenone
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:marketedAs
|
2000
|
|
gptkbp:mechanismOfAction
|
antiandrogenic
antimineralocorticoid
progestogenic
|
|
gptkbp:meltingPoint
|
196–198 °C
|
|
gptkbp:metabolism
|
hepatic
|
|
gptkbp:pregnancyCategory
|
gptkb:X_(US)
|
|
gptkbp:PubChem_CID
|
62073
68864
DB01395
|
|
gptkbp:relatedTo
|
gptkb:spironolactone
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
headache
breast tenderness
increased risk of blood clots
hyperkalemia
|
|
gptkbp:synonym
|
gptkb:DRSP
6β,7β;15β,16β-dimethylene-3-oxo-17α-pregn-4-ene-21,17-carbolactone
|
|
gptkbp:UNII
|
68X23937XM
|
|
gptkbp:usedFor
|
treatment of acne
treatment of premenstrual dysphoric disorder
contraception
hormone replacement therapy
|
|
gptkbp:bfsParent
|
gptkb:Yaz
gptkb:Yasmin
gptkb:Bayer_Yasmin_(contraceptive)
|
|
gptkbp:bfsLayer
|
6
|